Expanded hemodialysis: new opportunities and hopes

  • L. Surzhko State Institution «Institute of Nephrology of the National Academy of Medical Sciences of Ukraine»
Keywords: expanded hemodialysis, middle molecules, uremic toxins, hemodiafiltration, THERANOVA, high-flux membranes

Abstract

In the field of hemodialysis technologies, as in other fields of medicine, evolutionary changes are constantly taking place. The innovations are driven by unachieved clinical outcomes and desire to improve the quality of care of patients with CKD 5D. Recent advances in dialysis techniques resulted in the possibility to expand the permeability of dialysis membranes for a wider spectrum of uremic toxins that lead to the enhancement of long-term outcomes improving quality of life and reducing the mortality rate of dialysis patients. The inadequacy of existent dialysis techniques, at least in part, is due to the chronic accumulation of organic retention solutes of middle and large molecules, which are poorly or even not removed during dialysis.

A gradual improvement in the elimination of uremic toxins is observed as a result of the development of new alternative approaches of hemodialysis therapy, such as high-flux hemodialysis, hemodiafiltration, expanded hemodialysis (HDx). However, some techniques have had limited success due to a host number of organizational, technological, financial and human factors. Expanded hemodialysis offers a novel blood purification technology in removal of the large spectrum of uremic toxins, in particular large medium molecules, due to the new structure of the dialysis membrane. There are a number of studies that prove the potential benefits of a new method of dialysis therapy over the previous ones, suggesting a reduction in cardiovascular mortality, vascular calcification and inflammation. In addition, there is evidence of a positive effect of HDx on the quality of life in dialysis patients. In particular, to minimize the manifestations of skin itching, restless legs syndrome, asthenic syndrome.

Downloads

Download data is not yet available.

References

Thomas B, Wulf S, Bikbov B, Perico N, Cortinovis M, Courville de Vaccaro K, et al. Maintenance dialysis throughout the world in years 1990 and 2010. J Am Soc Nephrol 201;26:2621–33.  doi:10.1681/ASN.2014101017

Lowrie E, Laird N, Parker T, Sargent J. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981;305:1176–81. doi: 10.1056/NEJM198111123052003

Eknoyan G, Beck G, Cheung A, Daugirdas J, Greene T, Kusek J, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;347:2010–19. doi: 10.1056/NEJMoa021583

Kolesnyk MO, hol. redaktor. Natsionalnyi reiestr khvorykh na khronichnu khvorobu nyrok ta patsiientiv z  hostrym poshkodzhenniam nyrok: 2018 rik / uklad. NI Kozliuk, SS Nikolaienko, OО Razvazhaieva; Derzhavna ustanova «Instytut nefrolohii NAMN Ukrainy». Kyiv; 2019.178 s. [In Ukrainian].

Cheung A, Levin N, Greene T, Agodoa L, Bailey J, Beck G, et al. Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 2003;14:3251–63.   doi: 10.1097/01.asn.0000096373.13406.94.

Locatelli F, Martin-Malo A, Hannedouche T, Loureiro A, Papadimitriou M, Wizemann V, et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 2009;20:645–54. doi: 10.1681/ASN.2008060590.

Meert N, Eloot S, Schepers E, Lemke H, Dhondt A, Glorieux G, et al. Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities. Nephrol Dial Transplant 2011;26:2624–30. doi: 10.1093/ndt/gfq803.

Maduell F, Moreso F, Pons M, Ramos R, Mora-Macia J, Carreras J, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 2013;24:487–97. doi: 10.1681/ASN.2012080875.

Grooteman M, van den Dorpel M, Bots M, Penne E, van der Weerd N, Mazairac A, et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 2012;23:1087–96. doi: 10.1681/ASN.2011121140.

Ok E, Asci G, Toz H, Ok E, Kircelli F, Yilmaz M, et al. Mortality and cardiovascular events in online haemodiafiltration (OLHDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant 2013;28:192–202. doi: 10.1093/ndt/gfs407.

Van der Sande F, Kooman J, Konings C, Leunissen K. Thermal effects and blood pressure response during postdilution hemodiafiltration and hemodialysis: the effect of amount of replacement fluid and dialysate temperature. J Am Soc Nephrol 2001;12:1916–20.

Canaud B, Rodriguez A, Chenine L, Morena M, Jaussent I, Leray-Moragues H, et al. Whole-blood viscosity increases significantly in small arteries and capillaries in hemodiafiltration. Does acute hemorheological change trigger cardiovascular risk events in hemodialysis patient? Hemodial Int 2010;14:433–40. doi: 10.1111/j.1542-4758.2010.00496.x.

Kirsch AH, Lyko R, Nilsson L-G, Beck W, Amdahl M, Lechner P, et al. Performance of hemodialysis with novel medium cut-off dialyzers. Nephrol Dial Transplant 2017;32:165–72. doi: 10.1093/ndt/gfw310.

Krediet R, Zuyderhoudt F, Boeschoten E, Arisz L. Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients.Nephron 1986;42:133–140.

Zickler D, Schindler R, Willy K, Martus P, Pawlak M, Storr M, et al. Medium cut-off (MCO) membranes reduce inflammation in chronic dialysis patients – a Randomized Controlled Clinical Trial. PloS One 2017;12:e0169024.  doi: 10.1371/journal.pone.0169024.

Mathur V, Lindberg J, Germain M et al. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol 2010;5:1410–19. doi: 10.2215/CJN.00100110. 

Simonsen E, Komenda P, Lerner B et al. Treatment of uremic pruritus: a systematic review. Am J Kidney Dis 2017;70:638–55. Doi:10.1053/j.ajkd.2017.05.018.

Aoike I. Clinical significance of protein adsorbable membranes–long-term clinical effects and analysis using a proteomic technique. Nephrol Dial Transplant 2007;22:v13–9. doi: 10.1093/ndt/gfm295.

Florens N, Juillard L. Expanded haemodialysis: news from the field. Nephrol Dial Transplant. 2018;33(suppl_3):iii48–52. doi: 10.1093/ndt/gfy203.


Abstract views: 422
PDF Downloads: 18222
Published
2020-03-22
How to Cite
Surzhko, L. (2020). Expanded hemodialysis: new opportunities and hopes. Ukrainian Journal of Nephrology and Dialysis, (2(66), 47-51. https://doi.org/10.31450/ukrjnd.2(66).2020.07